NYSE: EFXEquifax Inc Stock
$163.71+4.13 (+2.59%)
Updated Jun 12, 2026
EFX Price
$163.71
Fair Value Price
N/A
Market Cap
$19.49B
52 Week Low
$153.91
52 Week High
$275.91
P/E
28.62x
P/B
4.29x
P/S
3.44x
PEG
0.96x
Dividend Yield
1.29%
Revenue
$6.28B
Earnings
$698.70M
Gross Margin
56.1%
Operating Margin
18.39%
Profit Margin
11.1%
Debt to Equity
1.6
Operating Cash Flow
$2B
Beta
1.13
Next Earnings
Jul 21, 2026
Ex-Dividend
N/A
Next Dividend
Jun 15, 2026
EFX Overview
Equifax Inc. is a consumer credit reporting agencies. Equifax collects and aggregates information on over 800M individual consumers and more than 88M businesses worldwide. In addition to credit and demographic data and services to business, Equifax sells credit monitoring and fraud prevention services directly to consumers. Equifax was founded in 1899 and is headquartered in Atlanta, GA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EFX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Consulting Service
Industry Rating
C
EFX
Ranked#2 of 17
Ranked#2 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $109.43 | C | |
| $72.76 | C | |
| $77.41 | C |
Be the first to know about important EFX news, forecast changes, insider trades & much more!
EFX News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EFX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EFX ($163.71) is trading above its intrinsic value of $88.27, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EFX is poor value based on its earnings relative to its share price (28.62x), compared to the US market average (14.15x)
P/E vs Market Valuation
EFX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more EFX due diligence checks available for Premium users.
Valuation
EFX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
28.62x
Industry
15.19x
Market
14.15x
EFX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EFX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
EFX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.29x
Industry
5.62x
EFX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EFX price to earnings growth (PEG)
For valuing profitable companies with growth potential
EFX is good value based... subscribe to Premium to read more.
PEG Value Valuation
EFX's financial health
Profit margin
Revenue
$1.6B
Net Income
$171.5M
Profit Margin
10.4%
EFX's Earnings (EBIT) of $1.16B... subscribe to Premium to read more.
Interest Coverage Financials
EFX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$11.9B
Liabilities
$7.3B
Debt to equity
1.6
EFX's short-term liabilities ($2.45B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EFX's long-term liabilities ($4.81B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EFX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EFX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$241.9M
Investing
-$120.4M
Financing
-$117.7M
EFX's operating cash flow ($1.63B)... subscribe to Premium to read more.
Debt Coverage Financials
EFX vs Consulting Service Stocks
Equifax Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.